Bank of America
ZBIO

Bank of America’s Zenas BioPharma ZBIO Stock Holding History

Bank of America’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.59M Buy
388,347
+341,187
+723% +$7.66M ﹤0.01% 3157
2025
Q4 		$1.71M Buy
47,160
+32,351
+218% +$1.06M ﹤0.01% 4189
2025
Q3 		$329K Buy
14,809
+818
+6% +$13.3K ﹤0.01% 6033
2025
Q2 		$136K Buy
13,991
+3,412
+32% +$33.2K ﹤0.01% 6367
2025
Q1 		$83.6K Sell
10,579
-10,996
-51% -$86K ﹤0.01% 6574
2024
Q4 		$177K Buy
+21,575
New +$337K ﹤0.01% 6172

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return

Bank of America's ZBIO Position: Q1 2026 in Review

Bank of America increased its Zenas BioPharma (ZBIO) stake by 723% in Q1 2026, buying an estimated $7.66M and bringing the position to 388,347 shares worth $7.59M. The position accounts for ﹤0.01% of the portfolio, ranked #3157.

Bank of America first reported a position in ZBIO in Q4 2024 and has held it in 6 quarters since. 139 funds tracked by Wall St. Rank hold ZBIO as of Q1 2026.

  • Bank of America held 388,347 shares of Zenas BioPharma worth $7.59M as of Q1 2026.
  • Bank of America bought 341,187 Zenas BioPharma shares in Q1 2026, an estimated $7.66M.
  • Zenas BioPharma made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3157 holding.
  • Bank of America first reported a position in Zenas BioPharma in Q4 2024 and has held it in 6 quarters since.
  • 139 funds tracked by Wall St. Rank held Zenas BioPharma as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.